Company ProfilePremium

Kingfa Sci. & Tech. Co., Ltd.

Company Profile Analysis

Ticker: 600143.SS金发科技股份有限公司

ESOMAR 23 Corporate BadgeISO Certifications Badge
Kingfa Sci. & Tech. Co., Ltd. - Company showcase

Year Founded & Workforce

1993

14,111 Employees

Kingfa Sci. & Tech. Co., Ltd. logo

Kingfa Sci. & Tech. Co., Ltd. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Kingfa Sci. & Tech. Co., Ltd. Overview

FieldDetailSource
Legal nameKingfa Sci. & Tech. Co., Ltd. (金发科技股份有限公司)[SPGMI]; [AR25]
Former namesGuangzhou Tianhe Hi-Tech Industrial Development Zone Kingfa Sci. & Tech. Development Co. (founded 22 May 1993); renamed Guangzhou Kingfa Sci. & Tech. Development Co., Ltd. in January 1996; later converted to a joint-stock company10jqka company profile
Founding year1993 (approval document (1993) Sui Tian Gao Qi Zi No. 105)10jqka company profile
Founder / actual controllerYuan Zhimin (袁志敏), 19.09% of total shares at 30 Jun 2026[F10]
Incorporation jurisdictionPeople's Republic of China (Guangzhou, Guangdong)[AR25]
HeadquartersNo. 33 Kefeng Road, Science City, Huangpu District, Guangzhou 510663, PRC; tel. +86 20 6681 8881[SPGMI] profile
Exchange / tickerShanghai Stock Exchange (Main Board): 600143 (A-shares). No H-share or overseas listing of the parent was identified.[SPGMI]; [F10]
ISINCNE000001JP3[SPGMI]
CUSIPNot applicable / not publicly disclosed (PRC A-share)—
Fiscal year end31 December[AR25]
Employees14,111 (FY2025); 10,629 (FY2023)[ESG] 2025 and 2023 reports
AuditorZhongshen Zhonghuan Certified Public Accountants (特殊普通合伙), unqualified opinion on FY2025[AR25] summary
Total sharesAbout 2,673 million shares at mid-2026 (2,635 million before the 2026 restricted-share grant); an EGM on 15 Sep 2026 approved cancelling repurchased sharesSouthwest Securities (Aug 2026); [F10]
Share priceCNY 12.76 (close, 30 Sep 2026)StockAnalysis.com quote
Market capitalisationAbout CNY 34.1 billion (analyst calculation: 12.76 × ~2,673 million shares). Roughly USD 4.8 billion at about CNY 7.1/USD (indicative only).Analyst calculation
Websitewww.kingfa.com.cn[SPGMI]
Industry classificationSpecialty Chemicals / Materials (S&P); "Basic Chemicals – Plastics – Modified Plastics" (Shenwan, as used by Guosen)[SPGMI]; Guosen

The entity profiled is the parent listed company Kingfa Sci. & Tech. Co., Ltd. (金发科技股份有限公司), a public company listed on the Shanghai Stock Exchange. The supplied company type ("Public company") is correct. It should not be confused with its listed Indian subsidiary, Kingfa Science & Technology (India) Ltd (NSE: KINGFA; BSE: 524019; formerly Hydro S&S Industries Ltd), which is a separately listed company controlled by the Chinese parent.

MetricFY2023FY2024FY2025
Employees (headcount)10,629—14,111
R&D personnel (headcount)——1,642

FY2025 R&D staff were 11.64% of the total ([IR26H1] summary citing [AR25]), which is consistent with a total of roughly 14,100.

Kingfa is the world's largest producer of modified (compounded) plastics by volume, with more than 4 million tonnes per year of compounding capacity and 2.95 million tonnes of finished modified-plastic sales in FY2025 [AR25; CLS 22 Apr 2026]. Over three decades the Guangzhou group has moved upstream and sideways from its original business of formulating polymer compounds for automotive, home-appliance and electrical OEMs. It now operates four platforms: modified plastics (the profit core); new materials (biodegradable polyesters where it claims global PBAT sales leadership, specialty engineering plastics such as LCP, high-temperature nylons, PPSU/PES/PEI and PEEK, and fibre-reinforced composites); "green petrochemicals" (PDH-based propylene, polypropylene, ABS, acrylonitrile and MMA at Ningbo and Liaoning); and medical/health polymers. The investment case rests on a widening gap between a high-quality, globally scaled compounding franchise with improving overseas and AI/robotics-linked mix, and a capital-heavy petrochemical arm that lost more than CNY 2.3 billion at subsidiary level in FY2025 and keeps consolidated ROE in low single digits.


What the company does — company description

Kingfa describes its principal business as the research, development, production and sale of new chemical materials. It lists nine product categories: modified plastics; environmentally friendly high-performance recycled plastics; fully biodegradable plastics; special engineering plastics; carbon fibre and composites (now "high-performance fibre-reinforced composites"); light hydrocarbons and hydrogen energy; polypropylene resins; styrenic resins; and medical and health polymer materials [AR25; SS-Apr26]. In its FY2025 operating discussion, management frames China as the world's largest producer and consumer of chemical new materials. It identifies two sources of opportunity: traditional end-markets (automotive, appliances) that remain steady, and emerging ones (new energy, embodied intelligence/humanoid robotics, low-altitude economy, high-frequency communications, AI and commercial aerospace). It also warns that domestic petrochemical overcapacity is pressuring its green petrochemical segment [AR25 via CFI.cn].

S&P's standardised description lists the same product families and adds rail transportation, aerospace, modern agriculture, modern logistics and high-end equipment as served industries [SPGMI].

Independent characterisation

Kingfa is best understood as a formulation-and-application engineering company that has bolted on a commodity petrochemical chain. Its value sits in three places:

  1. Compounding know-how and customer intimacy. The company formulates thousands of grades to OEM specifications, such as low-fog headlamp housings, flame-retardant appliance housings and battery-pack materials. In FY2025 Kingfa's average use per domestic passenger car exceeded 40 kg [AR25]. This business earns gross margins in the low-to-mid 20s.

  2. Upstream integration. Through the 2019–2021 acquisitions of Ningbo Haiyue (now Ningbo Kingfa) and Liaoning Baolai (now Liaoning Kingfa), and subsequent heavy capex of more than CNY 20 billion since 2020 [BF-Sep26], Kingfa added propane-to-propylene (PDH), polypropylene, ABS, acrylonitrile and MMA. Strategically, this secures feedstock (PP and ABS are the two largest compounding inputs). Financially, it has exposed the group to propane/propylene spreads that have collapsed: the spread fell from about CNY 4,050/t in H1 2021 to about CNY 1,965/t in H1 2026 [BF-Sep26].

  3. Optionality in high-performance polymers. These include LCP, PPA, PPSU/PES, PEI, PEEK, PI and transparent polyamides for AI servers, liquid cooling, optical modules, AR/VR and humanoid robots, plus biodegradable polyesters.

Business and revenue model

DimensionCharacterisation
Revenue modelEssentially 100% product sales (tonnage-based). No material subscription, licensing or service revenue is disclosed. "Other revenue" was CNY 474 million in FY2025 (0.7% of total) [SPGMI].
PricingCost-plus or formula-linked pricing for compounds, with lags in passing through resin cost. Petrochemical products are priced at market. Modified-plastic average selling price was about CNY 12,127/t in FY2025, against CNY 12,558/t in FY2024 (−3.4%) [SS-Apr26].
Value-chain positionMid-stream (compounding) with partial backward integration into monomers and resins (C3 and styrenics chains). There is limited forward integration into parts, except in medical products (gloves, masks).
Customer typesAutomotive OEMs and Tier-1s; appliance makers; electrical/electronics and consumer-electronics manufacturers; new-energy (PV, storage, EV batteries); communications/AI-server supply chains; packaging and film converters (biodegradables); industrial-protection channel distributors (gloves). The "333" goal targets Fortune Global 500 customers at more than 30% of the modified-plastics mix [Sina/新材料研习社, Sep 2025].
End-marketsAutomotive (largest), home appliances, electrical and electronics, consumer electronics, new energy, communications/AI hardware, robotics (designated the company's "ninth downstream industry" [BF-Sep26]), packaging/agriculture (biodegradables), medical/industrial protection, rail, aerospace.

FY2025 end-market volume indicators (modified plastics)

End-market (main products, global sales volume)FY2025 volume (kt)YoY growthSource
Home appliance materials501.3+19.70%[STCN]
Electrical and electronics materials462.2+18.09%[STCN]
New-energy materials111.7+31.41%[STCN]
Consumer-electronics materials131.0+25.96%[STCN]
Environment-friendly high-performance recycled materials256.3−10.35% (reclassification effect)[STCN]; [SS-Apr26]
Automotive materials (H1 2026 only)616.7 (H1 2026)+10.07%[IR26H1]

The decline in recycled materials is largely a reporting change. Recycled volumes that pass through compounding are now counted under automotive, appliance and consumer-electronics end-markets [SS-Apr26].

Strategy

Stated strategic themes

PeriodStated theme (paraphrased from filings)Source
2023 (long-term)"1438" strategy: CNY 100 billion output by 2030, comprising Medical & Health CNY 10 billion, Green Petrochemicals CNY 40 billion, New Materials CNY 30 billion, Modified Plastics CNY 80 billionQianzhan (Jan 2025); target reiterated in FY2024 annual report (Jiemian)
FY2025 management themeFocus on innovation-driven growth, improve organisational effectiveness, accelerate internationalisation[AR25] via [IR26H1]; CLS
H1 2026Three core strategies: internationalisation; synthesis-and-modification integration; new materials and new technologies[IR26H1]
Modified plastics "333" targetGlobal modified-plastics sales above 3 Mt; engineering plastics at 30% of volume; Fortune Global 500 customers above 30%Sept 2025 results call (Sina)
Shareholder-return frameworkAnnual "Improve Quality, Increase Efficiency, Return to Shareholders" (提质增效重回报) action plans since July 2024Action-plan assessment (Mar 2025); [IR26H1]

The "333" volume element (above 3 Mt) is effectively met on a run-rate basis: 2.95 Mt in FY2025 and 1.47 Mt in H1 2026 (+12.65%).

Strategic initiatives in the last 24 months

InitiativeDetailStatusSource
Overseas manufacturing build-outPoland and Mexico "large bases"; Spain and Vietnam (2024); Morocco subsidiary (2026)In progressHuaxin; [IR26H1]; [ESG]
Synthesis–modification integrationNingbo PP/TPE integration (capitalised Apr 2025); captive PP and ABS supply to compounding; differentiated ABS (weatherable, plating grade)Operating phase[IR26H1]
Petrochemical turnaroundPDH retrofit (restart H2 2026); ABS/MMA cost-reduction retrofits; "安稳长满优" (safe, stable, long-cycle, full-load, optimised) operating goalOngoing; losses persist[IR26H1]; Apr 2025 IR Q&A
Specialty engineering plastics expansion8 kt transparent/specialty PA (done Q2 2026); LCP phase II 10 kt (Q2 2027); 10 kt high-temperature PPA and 6 kt TPI (from Q1 2027); kiloton-scale PI; 50 kt specialty-plastics compounding plantExecutingHuaxin; [IR26H1]; Sina
AI compute and robotics materialsDedicated robotics R&D team; materials for AI servers, liquid cooling, optical modules; joint development and volume supply with UnitreeCommercial[BF-Sep26]; [IR26H1]
Biodegradables80 kt/yr biodegradable polyester project targeted mid-2026Progress not disclosed in H1 reportHuaxin; [IR26H1]
Medical diversificationNC membrane mass production; SEJ nonwoven (H2 2026); gloves channel expansionExecuting[IR26H1]
DigitalisationCNY 680 million invested in digital factories (2024), +50% per-capita efficiencyCompleted tranche[ESG] 2024
ComplianceGlobal compliance intelligence platform embedding rules into ERP/MES, focused on Western FDI screening and Southeast Asian regulationRolling out[IR26H1]
Capital returns2024 buyback (CNY 300–500 million); FY2025 payout raised to 46.37%; first interim dividend (CNY 0.10, 2026); cancellation of repurchased sharesExecuted / approvedAction-plan report; [IR26H1]; [F10]
Disciplined M&A stanceWill consider acquiring new-materials targets with core technology "while keeping free cash flow healthy"Policy statementApr 2025 IR Q&A (Securities Star)

Medium-term targets and guidance

Kingfa does not issue numeric annual earnings guidance. The quantitative targets on record are the "1438" 2030 output goal (CNY 100 billion) and the "333" modified-plastics goal. At the H1 2026 stage management characterised the industry as in a cyclical upturn with multiple positive factors, a more positive tone than the FY2025 report's description of the industry as "growing in volume, under pressure on profits, deeply differentiated" with the China chemical price index at about the 23rd percentile of its five-year range [IR26H1].

Products & Services

Pricing models are tonnage-based contract or spot pricing unless noted. Specific list prices are not publicly disclosed.

Modified Plastics

Product lineDescription and key capabilitiesTarget customersLatest status / flagship
Automotive materialsPP compounds, PC/ABS, PA, PBT, low-VOC interior grades, paint-free grades, battery-pack and e-drive materials, lamp-housing polyolefinsDomestic and global automakers, Tier-1s616.7 kt in H1 2026 (+10.07%). Average use above 40 kg per domestic passenger car in FY2025. Flagships: high-PCR, ultra-low-fog recyclable headlamp-housing polyolefin; polar polyolefin enabling engineering-plastic/polyolefin bonding for part integration [AR25]
Home-appliance materialsFlame-retardant HIPS/ABS/PP, high-gloss and antibacterial gradesAppliance OEMs501.3 kt in FY2025 (+19.70%); 278.0 kt in H1 2026 (+9.02%) [STCN; IR26H1]
Electrical and electronics materialsHalogen-free flame-retardant PA/PBT/PC, glow-wire gradesSwitchgear, connector, lighting makers462.2 kt in FY2025 (+18.09%) [STCN]
Consumer-electronics materialsPC/ABS, reinforced PC, cosmetic-surface gradesPhone, laptop and wearable supply chains131.0 kt in FY2025 (+25.96%); H1 2026 +23.31% [STCN; IR26H1]
New-energy materialsPV junction-box and frame materials, energy-storage enclosures, EV battery materialsPV, ESS, EV makers111.7 kt in FY2025 (+31.41%); H1 2026 +25.11% [STCN; IR26H1]
Robotics materials (sub-application)Carbon-fibre-modified nylon, bio-based PPA compoundsHumanoid-robot makers (joint development and volume supply with Unitree reported)Robotics designated the "ninth downstream industry" [BF-Sep26]
Environment-friendly high-performance recycled plasticsPost-consumer and post-industrial recycled PP/ABS/PC/PS, upgraded to OEM specsBrand owners with recycled-content targets256.3 kt in FY2025 (−10.35%, reclassification); 114.8 kt in H1 2026 (−3.20%) [STCN; IR26H1]

Capacity: more than 4 million t/yr of compounding capacity; 204 kt of modified plastics and 20 kt of recycled capacity under construction at end-2025 [CLS 22 Apr 2026; SS-Apr26]. A 50 kt/yr specialty-engineering-plastic compounding plant was under construction, with its first 15 kt phase targeted for Q2 2026 [Sina, Sep 2025].

New Materials

Product lineDescription and key capabilitiesTarget customersCapacity / status
Fully biodegradable plasticsPBAT, PBS, PLA-blend compounds for films, bags and mulchPackaging and film converters, agriculture226.3 kt sold in FY2025 (+25.37%); 144.5 kt in H1 2026 (+40.70%). About 180 kt/yr PBAT capacity, described as first in Asia (Oct 2025). Company claims global PBAT sales leadership and Asia #1 in biodegradable film/bag market share [DoNews Oct 2025; IR26H1]. 80 kt/yr biodegradable polyester project targeted mid-2026 (progress not disclosed in H1 report). 110 kt biodegradables capacity under construction at end-2025 [SS-Apr26]
High-temperature semi-aromatic polyamides (PPA, PA6T/PA10T; bio-based PPA)Heat-resistant, low-moisture nylons; halogen-free flame-retardant PPAConnectors, EV e-drive, robot dexterous-hand actuatorsAbout 21 kt/yr high-temperature nylon (Sep 2025). Halogen-free FR PPA about 2,600 t sold in H1 2026 (+44%). New 10 kt/yr high-temperature PPA planned from 2027 [Sina; IR26H1; Huaxin Apr 2026]
LCP (liquid crystal polymer)High-frequency, low-dielectric, thin-wall resin5G/6G antennas, AI-server high-speed connectors, optical modules6 kt/yr (Sep 2025). First 5 kt phase of a 15 kt/yr LCP resin project completed installation in 2025. Phase II 10 kt/yr due Q2 2027. LCP volumes +98.94% in H1 2025 [Sina; IR26H1]
Polyarylethersulfones (PPSU, PES, PSU)High-temperature, hydrolysis-resistant amorphous polymers; PFAS-free gradesLiquid-cooling quick-disconnect couplings (UQD), hollow-fibre membranes, AI high-speed copper cable and fibre-optic cablePPSU about 6.6 kt/yr. Membrane-grade PES in large-scale use. PFAS-free high-heat PAES adopted for AI high-speed copper and fibre cables [Sina; IR26H1]
PEI (polyetherimide)Heat-resistant amorphous resinAI-server heat-resistant componentsIn supply for AI servers [IR26H1]
PEEKUltra-high-performance semi-crystalline polymerRobot joints, harmonic reducersMarketed for robotics [BF-Sep26]; capacity not disclosed
Thermoplastic polyimide (TPI) / PIUltra-high-temperature resinAerospace, electronicsKiloton-scale PI project targeted end-2025. 6 kt/yr TPI planned from 2027 [Sina; Huaxin]
Transparent and specialty polyamidesSolvent-resistant microcrystalline transparent PA, PA elastomersAR/VR optics, eyewear, sports8 kt/yr first phase commissioned Q2 2026, within a 40 kt/yr programme. Microcrystalline transparent PA in scaled AR/VR use [IR26H1; Sina]
AI-compute specialty materials (aggregate)LCP, PEI, PPA, PPSU/PES for servers, connectors, optical modules, liquid-cooling and fansAI server/hardware supply chainAbout 6,750 t sold in H1 2026 (+50%) [IR26H1]
High-performance fibre-reinforced compositesContinuous and long-fibre thermoplastic composites (glass/carbon), CF-reinforced partsAutomotive lightweighting, rail, low-altitude aircraft, robotics torso structures23.4 kt sold and CNY 446 million revenue in FY2025 (+5.44%); CNY 272 million in H1 2026 (+28.91%). 61 kt under construction [SS-Apr26; IR26H1]
Bio-based monomers and flame retardantsInputs for bio-based polymers and FR compoundsInternal and external50 kt under construction at end-2025 [SS-Apr26]
Nitrocellulose (NC) membraneDiagnostic-grade membraneIVD test manufacturersStable mass production in H1 2026 [IR26H1]
SEJ nonwovenSpecialty nonwovenHygiene/medical/industrialIn commissioning; mass production expected H2 2026 [IR26H1]

Total special-engineering-plastic resin capacity was described as 39 kt/yr of semi-aromatic PA, LCP and PAES at end-2025 [Huaxin Securities, Apr 2026]. A September 2025 investor call cited about 34 kt in total [Sina]. The difference likely reflects additions in late 2025.

Green Petrochemicals

Asset / productDescriptionCapacity (as reported)Status
Ningbo Kingfa PDHPropane dehydrogenation to propylene, with by-product hydrogen1.2 Mt/yr PDHPDH unit undergoing technical retrofit; restart planned H2 2026 [IR26H1; Jiemian]
Ningbo Kingfa polypropyleneHomopolymer/copolymer PP and specialty PP800 kt/yr PPPP sales 910.1 kt in FY2025 (+13.85%, incl. captive); 372.8 kt in H1 2026 (−11.09%)
Ningbo PP/TPE integration project1.2 Mt/yr PP thermoplastic elastomer and modified-materials integration1.2 Mt/yrTransferred to fixed assets 30 Apr 2025; integrated products 122.6 kt in H1 2026
Liaoning Kingfa ABSEmulsion/continuous ABS; weatherable ABS and plating-grade ABS launched600 kt/yrABS sales 549.7 kt in FY2025 (+14.43%); 308.2 kt in H1 2026 (+26.52%)
Liaoning Kingfa PDHPropylene600 kt/yrOperating
Liaoning Kingfa acrylonitrileAN for ABS260 kt/yrOperating
Liaoning Kingfa MMAMethyl methacrylate100 kt/yrCost-reduction retrofit completed

Capacities are from Jiemian (2025); volumes from [IR26H1]. Liaoning Kingfa is described as the largest ABS producer in Northeast China.

Medical & Health

ProductDescriptionMetrics
Nitrile glovesIndustrial and medical disposable glovesMore than 4.7 billion units sold in FY2024 (+205.11%); entry into more than 100 overseas industrial-protection distributors [Jiemian]
Masks, melt-blown, protective productsLegacy COVID-era linesSegment revenue fell from about CNY 4.1 billion (2021) to CNY 563 million (2024) [Securities Star, Sep 2025]
Medical-grade polymers and new products (incl. NC membrane)Medical consumables materialsSegment revenue CNY 1,044 million in FY2025 (+85.44%); CNY 807 million in H1 2026 (+72.44%) with gross profit turning positive (+CNY 204 million YoY) [IR26H1]

Financial Narrative

All annual figures are from [SPGMI] unless noted. As-reported PRC GAAP headline figures (revenue CNY 65,396 million and net profit attributable CNY 1,150 million in FY2025) reconcile to [AR25].

Income statement

Notes:

  • The minority interest line is reported by [SPGMI] as positive figures that add to net income attributable: minorities absorb part of the losses at the non-wholly-owned petrochemical subsidiaries. This is why attributable net income (CNY 1,150 million) exceeds earnings from continuing operations (CNY 811 million) in FY2025.

  • As-reported FY2025 basic EPS was CNY 0.4459 [STCN].

Margins and growth

Revenue CAGR FY2021–FY2025: about 12.9% a year (analyst calculation: (65,396/40,199)^(1/4) − 1). Net income CAGR FY2021–FY2025: about −8.8% a year (1,150/1,661 over four years).

Commentary. Revenue growth has been driven mainly by volume. Modified-plastics tonnage compounded strongly, and from 2023 the green-petrochemical assets ramped up, adding low-margin tonnage. That is why gross margin fell from 16.1% (FY2021) to 10.9% (FY2024) even as revenue rose 51%. The FY2023 trough (net margin 0.66%) reflected three things at once: the PDH/ABS complexes started up into a cyclical low with weak utilisation, interest expense rose to CNY 1.08 billion as project debt came onto the P&L, and COVID-era medical profits disappeared.

The FY2024–FY2025 recovery came from:

  1. Compounding mix and scale (modified-plastics gross margin up 2.36 pp to 24.43% in FY2025, helped by lower resin costs);

  2. Fast growth in new materials;

  3. Lower interest expense (CNY 1,099 million to CNY 901 million);

  4. Larger minority-loss absorption.

Offsets were rising depreciation (D&A up from CNY 1.33 billion in FY2021 to CNY 2.50 billion in FY2025) and CNY 972 million of FY2025 impairments (CNY 207 million credit, CNY 765 million asset) [SS-Apr26]. The high effective tax rate (39.5% in FY2025) arises because loss-making petrochemical subsidiaries cannot offset taxable profits elsewhere in the group.

Interim and TTM trend

Sources: Futu/10jqka quarterly data; Securities Star (Q1 2026: revenue −0.49%, net profit +23.72%, non-GAAP +33.79%, gross margin 13.26%, debt ratio 65.26%); [IR26H1] (H1 2026 revenue +7.85%, net profit +17.02%, non-GAAP +14.69%; Q2 2026 revenue CNY 18,528 million, +16.02% YoY; Q2 net profit CNY 380 million, +12.14%); DoNews (9M 2025). H1 2025 non-GAAP is an analyst back-calculation.

An implied Q4 2025 net profit of about CNY 85 million (1,150 − 1,065) shows a weak fourth quarter, consistent with year-end inventory and asset impairments booked mainly at the petrochemical subsidiaries.

TTM to 30 Jun 2026 [SPGMI]: revenue CNY 67,878 million; EBITDA CNY 5,842 million (8.61% margin); net income CNY 1,249 million; EPS CNY 0.48; FCF CNY 4,897 million. H1 2026 gross margin was 13.12% (+0.83 pp YoY) and net margin 1.55% (+0.59 pp) [Guosen].

Balance sheet

As-reported FY2025 figures [SS-Apr26]: short-term borrowings CNY 4,537 million; current portion of non-current liabilities CNY 2,861 million; long-term borrowings CNY 15,920 million; cash CNY 4,344 million; accounts receivable CNY 8,433 million (on a narrower definition than S&P's figure, which includes notes and receivable financing); inventory CNY 7,916 million.

Latest balance sheet.

  • At 31 Mar 2026: cash CNY 7,483 million; short-term borrowings CNY 5,073 million; current portion of LT debt CNY 3,498 million; long-term debt CNY 18,812 million [SPGMI]. [SS-Apr26] gives long-term borrowings of CNY 17,810 million; the difference likely reflects bonds and other long-term payables included by S&P. Net debt was CNY 19,985 million.

  • At 30 Jun 2026: cash CNY 7,624 million (+75.53% vs start of year); short-term borrowings CNY 6,587 million (+45.16%); receivable financing CNY 2,040 million (down from CNY 3,654 million); notes payable +48.44%; total assets CNY 67,819 million; BVPS CNY 7.35 [IR26H1; Southwest Securities].

Commentary. The CNY 15.8 billion growth in total assets from FY2021 to FY2025 was essentially the petrochemical build-out. Construction in progress peaked at CNY 13.3 billion in FY2022 and has since been largely capitalised; machinery rose from CNY 10.1 billion to CNY 25.3 billion. Net debt peaked at CNY 23.7 billion in FY2024 and fell to CNY 20.1 billion in FY2025 as FCF turned strongly positive. Leverage remains elevated: the liability ratio was 65.3% at Q1 2026, and short-term interest-bearing debt exceeded CNY 8.5 billion at Q1 2026 against CNY 7.5 billion of cash. Goodwill is now immaterial after the CNY 201 million FY2024 impairment.

Cash flow

Notes: "Dividends paid" in [SPGMI] includes interest and dividends paid through financing activities under PRC cash-flow presentation, so it overstates pure common dividends. FY2025 common cash dividend declared was CNY 533 million (DPS CNY 0.20; 46.37% payout) [IR26H1]. TTM to Jun 2026: OCF CNY 7,070 million; capex CNY 2,173 million; FCF CNY 4,897 million.

Commentary. FY2025 marks a cash-flow inflection. Capex normalised to about CNY 2.3 billion after peaking at CNY 7.1 billion in FY2022, and OCF doubled (+107.52%) to CNY 5.9 billion. Management attributes the OCF gain to supply-chain settlement optimisation. Balance-sheet evidence supports this: Kingfa shifted collections to telegraphic transfer (receivable financing −44%, notes receivable −32%) while paying suppliers with more bills (notes payable +48%) [IR26H1]. Part of the FCF improvement is therefore working-capital engineering, which is reversible, rather than purely earnings-driven.

Returns, leverage and efficiency ratios

Sources: [SPGMI] ratios. The S&P ROE figures above appear inconsistent with net income divided by equity (e.g., FY2025 1,150/19,471 ≈ 5.9%) and likely reflect a different numerator; the as-reported weighted ROE of 6.22% for FY2025 (+1.39 pp) is from [IR26H1], and FY2024's 4.83% is implied. Interest coverage and DSO/DIO/DPO/CCC are analyst calculations from [SPGMI] year-end balances (receivables use S&P's broad accounts-receivable line).

Commentary. Returns remain well below the cost of capital. ROIC of about 4% in FY2025 compares with 9.9% in FY2021. Restoring double-digit returns depends almost entirely on the petrochemical subsidiaries moving to break-even: their combined CNY 2.3 billion FY2025 loss is about twice group attributable net profit. Leverage has de-risked from the FY2023 peak (net debt/EBITDA from 6.8x to 3.7x) but is still high for a cyclical. The current ratio near 1.1–1.2x reflects heavy reliance on rolling short-term bank funding, which is typical of large private Chinese chemical groups.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentContentsMain legal entities (where disclosed)

Modified Plastics (改性塑料)

Engineering and general-purpose compounds; environment-friendly high-performance recycled plastics (PCR/PIR)

Parent (Guangzhou) and domestic bases; overseas bases in India, Vietnam, Malaysia, USA, Europe/Spain, with Poland and Mexico under construction

New Materials (新材料)

Fully biodegradable plastics (PBAT/PBS/PLA blends); special engineering plastics (PPA, LCP, PPSU/PES/PEI, PEEK, PI, transparent PA); high-performance fibre-reinforced composites

Zhuhai Wantong Special Engineering Plastics; Kingfa biodegradables units; Kingfa composites units

Green Petrochemicals (绿色石化)

Light hydrocarbons and hydrogen (PDH propylene and by-product hydrogen), polypropylene resins, styrenics (ABS), acrylonitrile, MMA

Ningbo Kingfa (PDH, PP, PP/TPE integration); Liaoning Kingfa (PDH, ABS, AN, MMA)

Medical & Health (医疗健康)

Nitrile gloves, masks/protective products, medical-grade polymers, melt-blown materials

—

Trading products (贸易品)

Resale of resins and chemicals

Group trading entities

Segment revenue (CNY Mn)

Segment revenue (CNY Mn)FY2023FY2024FY2025

Modified Plastics

—32,07635,781

New Materials

—3,6534,369

Green Petrochemicals

9,35111,436—

Medical & Health

3855631,044

Green Petrochem + Trading + Medical combined

——24,772

Total operating revenue (group)

47,94160,51465,396

Revenue by Segment (%) and Segment Margins & Growth (%)

Metric (%)FY2024FY2025

Modified Plastics share of revenue

53.054.7

New Materials share of revenue

6.06.7

GP + Trading + Medical share of revenue

—37.9

Modified Plastics gross margin

22.0724.43

New Materials gross margin

—20.59

Green Petrochemicals gross margin

-6.36-5.30

Group gross margin (as reported)

—13.33

Volume (kt)

Volume (kt)FY2023FY2024FY2025

Modified plastics finished-product sales

—2,5522,951

New materials sales

—236284

Biodegradable plastics (main products)

144181226

Special engineering plastics (main products)

—2434

Fibre-reinforced composites (main products)

——23

Ningbo Kingfa polypropylene (incl. captive)

—799910

Liaoning Kingfa ABS (incl. captive)

—480550

Overseas-base finished products

—234298

Subsidiary net profit (CNY Mn)

Subsidiary net profit (CNY Mn)FY2023FY2025

Ningbo Kingfa

-721-1,017

Liaoning Kingfa

-1,162-1,286

Revenue by Segment

Metric (CNY Mn)H1 2025H1 2026

Modified Plastics revenue

16,47318,167

New Materials revenue

1,9902,814

New Materials gross profit

380601

Medical & Health revenue

468807

Fibre-reinforced composites revenue

211272

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (CNY Mn)

40,19940,41247,94160,51465,396

Revenue growth (%)

14.650.5318.6326.238.07

Gross profit (CNY Mn)

6,4665,9195,5436,6138,384

SG&A (CNY Mn)

1,8501,6672,1602,3832,676

R&D expense (CNY Mn)

1,4551,4541,9732,4902,761

Operating income / EBIT (CNY Mn)

2,9032,5801,4161,8442,894

EBITDA (CNY Mn)

4,2304,0243,2623,8935,397

D&A for EBITDA (CNY Mn)

1,3271,4441,8472,0492,503

Interest expense (CNY Mn)

6318901,0831,099901

Asset write-downs (CNY Mn)

70233294215682

Goodwill impairment (CNY Mn)

65742013

Pre-tax income (CNY Mn)

1,9022,0281644641,341

Income tax (CNY Mn)

2452795225530

Minority interest in earnings (CNY Mn)

5-9248586339

Net income attributable (CNY Mn)

1,6611,9923178251,150

Non-GAAP (deducted) net profit (CNY Mn)

—1,3411986751,065

EPS basic (CNY)

0.650.770.120.310.45

EPS diluted (CNY)

0.650.770.120.310.45

Dividends per share (CNY)

0.200.230.100.100.20

Effective tax rate (%)

12.901.3558.0948.5139.53

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin (%)

Margin (%)FY2021FY2022FY2023FY2024FY2025

Gross margin (%)

16.0914.6511.5610.9312.82

Operating (EBIT) margin (%)

7.226.392.953.054.42

EBITDA margin (%)

10.529.966.806.438.25

Net margin (attributable) (%)

4.134.930.661.361.76

R&D / revenue (%)

3.623.604.124.114.22

Income Statement

Metric (CNY Mn)Q1 2025H1 20259M 2025FY2025Q1 2026H1 2026

Revenue (CNY Mn)

15,66631,63649,61665,39615,59034,118

Net profit attributable (CNY Mn)

2475971,0651,150305685

Non-GAAP net profit (CNY Mn)

—536—1,065288615

Balance Sheet and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (CNY Mn)

48,30055,43461,57561,79964,068

Cash and equivalents (CNY Mn)

4,0473,9773,7353,5404,344

Accounts receivable (CNY Mn)

8,4768,51711,25810,42212,373

Inventory (CNY Mn)

5,1645,5496,0397,4117,916

PP&E (CNY Mn)

20,44325,42428,82628,52628,547

Construction in progress (CNY Mn)

8,48313,3228,2297,2582,685

Goodwill (CNY Mn)

3342772737269

Other intangibles (CNY Mn)

3,0473,4443,5963,5173,719

Goodwill + intangibles (CNY Mn)

3,3813,7213,8693,5893,788

Short-term debt (CNY Mn)

3,3193,1095,7286,5924,537

Current portion of LT debt (CNY Mn)

1,3703,9633,1092,0602,841

Total short-term debt (CNY Mn)

4,6897,0728,8378,6527,378

Long-term debt (CNY Mn)

13,05415,05817,00318,54216,916

Total debt incl. leases (CNY Mn)

17,82622,20225,89727,23124,412

Net debt (CNY Mn)

13,77918,22522,14123,65620,068

Total liabilities (CNY Mn)

31,58137,14743,66041,18341,378

Equity attributable to parent (CNY Mn)

14,98716,52916,34917,96219,471

Minority interest (CNY Mn)

1,7321,7581,5662,6543,219

Total equity (CNY Mn)

16,71918,28717,91520,61622,690

Working capital (CNY Mn)

2,263-541-532,5423,931

Book value per share (CNY)

5.826.226.116.957.57

Cash Flow and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (CNY Mn)

2,2153,4322,4062,8455,904

Capital expenditure (CNY Mn)

6,2997,0824,3232,3842,328

Free cash flow (CNY Mn)

-4,084-3,650-1,9174623,576

Change in working capital (CNY Mn)

-2,068-859-1,009-1,342328

Dividends paid (CNY Mn)

2,0831,3831,8111,1461,076

Share repurchases (CNY Mn)

00055283

Net debt issued/(repaid) (CNY Mn)

7,4973,9643,2641,028-2,902

Cash acquisitions (CNY Mn)

7120000

FCF margin (%)

-10.16-9.03-4.000.765.47

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2021FY2022FY2023FY2024FY2025

ROE (%)

10.4411.430.381.243.75

ROE weighted average, as reported (%)

———4.836.22

ROA (%)

4.493.111.511.872.87

ROIC (%)

9.917.601.552.254.02

ROCE (%)

9.407.503.704.607.00

Current ratio (x)

1.130.971.001.121.17

Quick ratio (x)

0.730.620.650.670.74

Debt / equity (x)

1.071.211.451.321.08

Net debt / equity (x)

0.821.001.241.150.88

Net debt / EBITDA (x)

3.264.536.796.083.72

Debt / EBITDA (x)

4.205.497.886.964.46

Interest coverage EBIT/interest (x)

4.602.901.311.683.21

Asset turnover (x)

1.000.780.820.981.04

Inventory turnover (x)

7.366.447.328.027.44

DSO (days)

77.076.985.762.969.1

DIO (days)

55.958.752.050.250.7

DPO (days)

66.176.065.654.168.0

Cash conversion cycle (days)

66.859.672.159.051.8

Region revenue (CNY Mn)

Region revenue (CNY Mn)H1 2025H1 2026

Overseas sales

5,0586,295

Domestic sales

26,57827,823

Revenue by Region and Operating Metrics (kt)

Overseas-base metrics (CNY Mn)FY2024FY2025

Overseas-base operating revenue (CNY Mn)

3,1324,234

Overseas-base finished-product volume (kt)

234298

Country / Entity Details

Country / entityMetricValueSource

India — Kingfa Science & Technology (India) Ltd

FY2025 (year to Mar 2025) revenue from operations

INR 17,446.9 million (+17.27%)

[KFI] directors' report

India — Kingfa India

FY2025 profit after tax

INR 1,528.6 million (+24.76%)

[KFI]

India — Kingfa India

Q3 FY2026 (Dec 2025 quarter) sales / net profit

INR 4,894.6 million (+11.15%) / INR 451.7 million (+30.44%)

Arihant Capital (Feb 2026)

India — Kingfa India

H1 2026 net profit (CNY, parent's reporting basis)

CNY 101 million (+63.75%)

[IR26H1]

Vietnam — Kingfa Vietnam

H1 2026 net profit

CNY 73 million (+420.85%)

[IR26H1]

India and Vietnam

Market position

Largest modified-plastics producers in their respective countries (company claim)

[IR26H1]

Overseas automotive (South Asia, North America, Southeast Asia)

Market share

Rising (qualitative)

[AR25]

Capital Markets Data (CNY) and Market Valuation

MetricFY2021FY2022FY2023FY2024FY2025

Year-end close (CNY)

11.519.077.688.4419.29

Year-end market cap (CNY Mn)

32,37625,74821,34922,32050,273

Market cap growth (%)

-26.60-20.47-17.084.55125.24

Performance to 30 Sep 2026 Details

Performance to 30 Sep 2026 (close CNY 12.76)Return (price only)

YTD 2026 (from 19.29)

−33.9%

~1 year (from about 20.99, 30 Sep 2025)

−39.2%

~3 years (from 7.68, end-2023, proxy)

+66.1%

~5 years (from 11.51, end-2021, proxy)

+10.9%

52-week range

CNY 12.76–24.08 (low per 30 Sep close; Guosen gives 13.04–24.08 as of late Aug)

Valuation Multiples

MultipleCurrent (30 Sep 2026, analyst calc.)7 Aug 2026 [SPGMI]FY2025 year-end [SPGMI]FY2024 year-end [SPGMI]

P/E (TTM)

≈26.6x (12.76 / 0.48)

33.3x43.7x27.1x

Forward P/E (FY2026E)

≈20.3x (on Southwest EPS of CNY 0.63)

22.0x31.0x18.0x

EV/EBITDA (TTM)

≈9.7x

11.1x14.2x12.7x

EV/Sales

≈0.84x

0.98x1.17x0.82x

P/B

≈1.74x (BVPS CNY 7.35)

1.80x2.22x1.08x

Dividend yield (trailing CNY 0.30)

≈2.4%

1.23%1.04%1.18%

Capital Markets

ItemDetailSource

Ratings (last 90 days, as of 2 Sep 2026)

7 institutions: 5 Buy, 2 Overweight

Stockstar research digest

90-day average target price

CNY 16.24 (about 27% upside from CNY 12.76)

Same

Earlier (24 Jun 2026)

13 institutions: 8 Buy, 5 Overweight; average target CNY 20.23

Securities Star

Southwest Securities (initiation, 27 Aug 2026)

Buy; target CNY 17.64 (28x FY2026E P/E)

Southwest

Guosen Securities (27 Aug 2026)

Outperform (maintained)

Guosen

Huaxin Securities (22 Apr 2026)

Buy (maintained)

Huaxin

Northeast Securities FY2026E net profit

CNY 1.57 billion

Stockstar

Income Statement and Per-Share Data

Forecast metricFY2025FY2026FY2027FY2028

Revenue (CNY Mn)

65,39672,41478,98385,317

Net profit attributable (CNY Mn)

1,1501,6762,1902,858

EPS (CNY)

0.450.630.821.07

ROE (%)

5.918.079.6811.42

Per-Share Data and Returns & Leverage Ratios (%)

MetricFY2021FY2022FY2023FY2024FY2025

DPS declared (CNY)

0.200.230.100.100.20

Payout ratio (% of net profit, S&P basis)

125.3969.43571.85139.0393.58

Share repurchases (CNY Mn)

00055283

Capital Markets — Moody's / S&P / Fitch

ItemDetail

Moody's / S&P / Fitch

None identified (not publicly rated by the three international agencies)

Debt due within one year (FY2025)

CNY 7,378 million (short-term debt CNY 4,537 million + current LT debt CNY 2,841 million) vs cash CNY 4,344 million

Debt due within one year (Q1 2026)

CNY 8,571 million vs cash CNY 7,483 million

Long-term debt (FY2025 / Q1 2026)

CNY 16,916 million / CNY 18,812 million [SPGMI] (CNY 15,920 million / CNY 17,810 million long-term borrowings as reported)

Debt activity, FY2025

Issued CNY 23,020 million; repaid CNY 25,922 million (net repayment CNY 2,902 million)

Interest expense

CNY 901 million in FY2025 (implied average cost about 3.5% on average debt of about CNY 25.8 billion, analyst calc.)

Analyst Conclusions

Management guidance

No numeric earnings guidance is issued. Management's H1 2026 commentary describes the industry as entering a cyclical recovery, while flagging cost pass-through pressure from Middle East-driven feedstock volatility [IR26H1]. Operational milestones guided for the next 12 months:

  • PDH restart after retrofit (H2 2026);

  • SEJ nonwoven mass production (H2 2026);

  • LCP phase II, high-temperature PPA and TPI from Q1–Q2 2027;

  • continued Poland, Mexico and Morocco build-outs.

Consensus expectations

Southwest expects revenue growth of 10.7% in FY2026 (to CNY 72.4 billion) and net profit of CNY 1.68 billion (+45.8%). Northeast Securities expects CNY 1.57 billion. Delivering either figure implies H2 2026 net profit of CNY 0.9–1.0 billion, versus CNY 553 million in H2 2025 (analyst calculation: 1,150 − 597). That step-up would require a meaningful reduction in petrochemical losses.

Bull case

  1. Core earnings power is under-recognised. Modified plastics (CNY 35.8 billion revenue at about 24% gross margin) and new materials (CNY 4.4 billion at about 21%, growing about 40%) generate roughly CNY 9.6 billion of gross profit (analyst calculation). If petrochemical losses of about CNY 2.3 billion a year halve, attributable profit could approach CNY 2 billion or more, matching the FY2022 peak.

  2. FCF and capital returns have inflected. Capex has normalised at about CNY 2.2–2.3 billion a year against OCF of CNY 5.9–7.1 billion. Kingfa has introduced interim dividends, raised its payout to 46% and is cancelling about 62 million repurchased shares. TTM FCF yield at about CNY 34 billion market cap is roughly 14%.

  3. Secular growth vectors are real and visible. AI-compute materials (+50%), specialty engineering plastics (+47% volume), overseas sales (+24%) and robotics references (Unitree) offer structural growth that a 0.84x EV/Sales multiple does not price.

Bear case

  1. The petrochemical anchor may persist. PP/ABS oversupply in China is structural, and the propane/propylene spread has more than halved since 2021. Losses widened at Ningbo in H1 2026 (−CNY 681 million) despite management focus, and more than CNY 20 billion of sunk capex earns negative returns.

  2. Balance-sheet and earnings quality. Net debt is CNY 20 billion, short-term debt exceeds cash, CNY 972 million of FY2025 impairments were recorded, and part of the OCF gain comes from reversible supplier-bill financing.

  3. Governance and theme risk. The controlling founder has a criminal record. High executive pay and large option-like grants accompany a ROIC of about 4%. The 2025 re-rating was driven by retail "robotics proxy" flows that are now unwinding (−39% over one year).

Catalysts and monitorables (next 12 months)

Catalyst / monitorableTimingWhy it matters
Q3 2026 resultsLate Oct 2026Tests the H2 profit step-up implied by consensus
Ningbo PDH restart and petrochemical subsidiary P&LH2 2026 – H1 2027Single largest earnings swing factor
Propane–propylene and ABS spreadsContinuousDrives petrochemical losses
FY2026 annual report and dividendApr 2027Payout policy; impairments
LCP phase II / PPA / TPI commissioningQ1–Q2 2027Specialty growth capacity
Poland and Mexico base start-ups2026–2027Overseas growth and tariff hedge
Repurchased-share cancellation completionQ4 2026EPS accretion of about 2%
Working-capital normalisation (bills payable, receivable financing)QuarterlySustainability of FCF
FX moves (USD/EUR/CNY)ContinuousFinancial-expense volatility
Founder and related-party share salesOngoingSupply overhang

Concluding analyst verdict

Kingfa is two companies sharing one balance sheet. The first is a world-class, globally localised compounding and specialty-polymer franchise. In FY2025 it sold 2.95 million tonnes of modified plastics at roughly 24% gross margin, and it grew new materials, overseas sales and AI- and robotics-linked specialty grades at 25–50% rates into mid-2026. On a standalone basis this business would likely trade at a premium to Chinese compounding peers and earn mid-teens returns. The second is a set of PDH, polypropylene and ABS complexes at Ningbo and Panjin, built with more than CNY 20 billion of capital at the top of the cycle. They lost about CNY 2.3 billion in FY2025 and more than CNY 1.3 billion in H1 2026, and they explain why consolidated ROIC is about 4% and net debt is still about CNY 20 billion.

The FY2025–H1 2026 data mark a genuine inflection in cash generation. Capex has halved and OCF has doubled, which funds rising dividends and buyback cancellations. Valuation has also reset: at about CNY 12.8 the shares trade near 20x consensus FY2026 earnings, under 10x TTM EBITDA and about 1.7x book, well below the speculative 2025 peak. The equity is therefore increasingly a call option on petrochemical loss reduction, underpinned by a resilient core.

The balance of evidence supports a constructive but conditional stance. Upside is credible if PDH retrofits and integration cut subsidiary losses by roughly half and if working-capital gains prove durable. If petrochemical spreads stay at 2026 levels, consolidated returns will remain sub-economic, and governance factors (a controlling shareholder with an insider-trading conviction, generous management grants) will continue to cap the multiple. Investors should key decisions to Q3–Q4 2026 petrochemical subsidiary losses, net-debt trajectory and the sustainability of operating cash flow, rather than to robotics-themed newsflow.


End of dossier. All figures in CNY unless stated; fiscal years end 31 December. "Analyst calculation" denotes arithmetic derived from cited inputs. This document is informational and is not investment advice.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameTitleTenure in current roleBackgroundAge / educationFY2025 pre-tax compensation

Chen Pingxu (陈平绪)

Chairman

Since May 2024

Career Kingfa executive; previously director and deputy GM

—

CNY 4.479 million; 4.0 million restricted shares granted in 2026 at CNY 9.52

Wu Di (吴敌)

Director and General Manager (CEO); also leads marketing

Since May 2024

Career Kingfa executive; previously director and deputy GM

—

CNY 4.312 million; 4.0 million restricted shares in 2026

Yuan Changchang (袁长长)

Vice Chairman and Executive Deputy GM

Board since May 2024

Son of founder Yuan Zhimin

——

Ning Hongtao (宁红涛)

Director (former Board Secretary)

Board since at least May 2024

Former board secretary

Born 1970s

—

Lei Changan (as listed by S&P/EODHD)

Chief Financial Officer

————

Huang Hesheng (as listed)

Deputy General Manager

————

Li Peng (as listed)

Director and Deputy GM

————

Dai Yaoshan (as listed)

Board Secretary

————

Zheng Hefen (as listed)

Accounting Supervisor

————

Gu Xiaodong (古小东)

Independent Director (nominee)

————

“—” = not publicly disclosed.

Governance Overview

AttributeDetail

Board term

8th Board, elected at the 2023 AGM on 21 May 2024

Non-independent directors

Seven, of whom four were new faces in 2024; six born in the 1980s; all career Kingfa employees (Shifair/Jiemian)

Chair/CEO separation

Yes: Chairman Chen Pingxu and GM Wu Di are different people

Departures in 2024

Yuan Zhimin (Chairman), Li Nanjing (GM), Xiong Haitao, Li Jianjun left the board

Board & Management Changes

DateChangeContext

21 May 2024

Chen Pingxu → Chairman; Wu Di → GM; Yuan Changchang joins board

Succession following criminal case against founder

Jul 2024

Founder sentenced (3 years, suspended 4)

Insider trading conviction

Nov 2024

Management-led Guangzhou Kingfa Industrial Investment Co. formed

Subsidiary-level equity incentives

2026

Restricted-share plan: 38.4723 million shares at CNY 9.52 to 1,130 grantees; Chairman and GM each 4 million (20.79% combined)

Retention and alignment; grant-date price about CNY 17.5

2026

2026 ESOP holds 54.8677 million shares (2.05%)

Employee ownership

15 Sep 2026

EGM: independent-director election; repurchased shares redirected to cancellation

Capital-management signal

Major Shareholders

RankHolderShares (million)% of totalChange vs 31 Mar 2026
1

Yuan Zhimin (founder, actual controller)

510.019.09

Unchanged

2

Li Nanjing (former GM)

91.783.43

Unchanged

3

Hong Kong Securities Clearing (Northbound Stock Connect)

67.542.53

+36.32 million (+116%)

4

Song Ziming

57.062.13

Unchanged

5

Kingfa 2026 Employee Stock Ownership Plan

54.872.05

New

6

Xiong Lingyao

45.001.68

Unchanged

7

Xiong Haitao (founder's ex-wife)

39.741.49

Unchanged (sold about 29 million shares across 2025–Q1 2026)

8

Huabao Wanying Gaoheng No. 4 private fund

26.070.98

Unchanged

9

Huabao Wanying Gaoheng No. 1 private fund

26.070.98

Unchanged

10

Huamei Chuancheng No. 3 private fund

23.020.86

−0.52 million

—

Top 10 combined

94235.22

+52.75 million

Competitive Landscape

Competitors by Segment

SegmentCompetitorCountryPositioning vs Kingfa

Modified plastics (China)

Qingdao Gon Technology (国恩股份, 002768)

China

#2-tier domestic compounder; diversified into gelatine and other materials; smaller scale

Modified plastics (China)

Shanghai Pret Composites (普利特, 002324)

China

Automotive-focused compounder; also owns battery business

Modified plastics (China)

Shandong Dawn Polymer (道恩股份, 002838)

China

Elastomers (TPV) and compounds; higher gross margin

Modified plastics (China)

Huitong New Materials (会通股份, 688219)

China

Appliance/automotive compounds

Modified plastics (China)

Silver Age / Yinxi (银禧科技), Nanjing Julong (南京聚隆), Juseng (聚石化学)

China

Niche compounders

Engineering plastics (global)

BASF (Performance Materials), Celanese (Engineered Materials), SABIC (Specialties), Covestro, Envalior (ex-DSM Engineering Materials + LANXESS HPM), LG Chem, Lotte Chemical, Polyplastics

Global

Higher-margin base-resin owners; strong OEM global approvals

Special engineering plastics / LCP

Shenzhen Wote (沃特股份, 002886), Polyplastics, Celanese, Sumitomo Chemical, Ueno, Solvay/Syensqo (PPSU/PES), Victrex (PEEK), Kingfa vs Kingfa-like Chinese entrants

Global/China

Global incumbents dominate PEEK/PPSU; Kingfa an emerging challenger

Biodegradables

Xinjiang Blue Ridge Tunhe (蓝山屯河), Jinhui Zhaolong (金晖兆隆), Hengli Petrochemical, Novamont (Versalis)

China/EU

Kingfa claims global PBAT sales leadership

PDH / PP

Oriental Energy (东华能源), Satellite Chemical (卫星化学), Wanhua Chemical, Hengli Petrochemical, Zhongjing Petrochemical (中景石化)

China

Larger, more integrated players driving overcapacity

ABS

Chimei, LG Chem, INEOS Styrolution, Zhejiang Petrochemical, Wanhua (new capacity)

Global/China

Kingfa a mid-scale ABS producer in a long market

Peer Comparison FY2025

CompanyRevenue (CNY Bn)Revenue growthGross marginNet profit (CNY Bn)R&D intensityPeriod

Kingfa

65.40+8.07%

12.8% (S&P) / 13.33% (reported)

1.1504.22%

FY2025

Kingfa

34.12+7.85%13.12%0.6854.13%

H1 2026

Qingdao Gon (国恩股份)

11.51—13.28%0.655—

Latest period on 10jqka screen (likely H1 2026)

Shanghai Pret (普利特)

5.627—10.62%0.084—

Same

Dawn Polymer (道恩股份)

3.978—16.15%0.237—

Same

Pret (FY2025 preliminary)

———

0.361–0.416

—

FY2025 forecast (Jan 2026)

Recent Developments

Layoffs, guidance revisions or regulatory actions in the period: **none identified.

Company Snapshot

$9,095.4M

Revenue

14,111

Employees

$4,800M

Market Cap

1993

Founded

Guangzhou, China

Headquarters

SWOT Analysis

Strengths

  • Global volume leadership: 2.95 Mt modified-plastics sales in FY2025 (+15.64%), four consecutive record years [CLS, Apr 2026].
  • Superior core margins: modified-plastics gross margin 24.43% in FY2025 (+2.36 pp), the highest among listed Chinese peers [SS-Apr26; Qianzhan].
  • Cash generation turnaround: OCF CNY 5.90 billion (+107.52%) and FCF CNY 3.58 billion in FY2025, against −CNY 4.08 billion FCF in FY2021 [SPGMI].
  • Overseas franchise: overseas sales +24.46% in H1 2026; India net profit +63.75%; Vietnam net profit +420.85% [IR26H1].
  • Innovation depth: R&D CNY 2.76 billion (4.22% of revenue); 7,621 cumulative patent applications; national innovation platforms [IR26H1].
  • High-growth niches already commercial: new materials revenue +41.38% and gross profit +58.23% in H1 2026; AI-compute materials about 6,750 t (+50%) [IR26H1].

Weaknesses

  • Loss-making petrochemicals: Ningbo and Liaoning lost CNY 2.30 billion combined in FY2025 and CNY 1.33 billion in H1 2026, against group net profit of CNY 1.15 billion and CNY 0.685 billion [IR26H1].
  • Low consolidated returns: ROIC 4.0% and net margin 1.76% in FY2025 [SPGMI].
  • Leverage: net debt CNY 20.1 billion (3.7x EBITDA); short-term interest-bearing debt above CNY 8.5 billion at Q1 2026 [SPGMI; SS-Apr26].
  • Impairments: CNY 972 million in FY2025, including petrochemical inventory and idle medical assets (CNY 134 million) [SS-Apr26].
  • Negative-margin businesses: petrochemicals, trading and medical (37.9% of revenue) all had negative gross margins in FY2025 [SS-Apr26].
  • Governance overhang: the founder (19.09% holder) has a criminal conviction for insider trading (2024) [BF-Sep26].

Opportunities

  • AI hardware materials (LCP for connectors, PAES for liquid cooling, PEI), with LCP phase II in 2027 [IR26H1; Huaxin].
  • Humanoid robotics: joint development and volume supply with Unitree; robotics designated a strategic end-market [BF-Sep26].
  • Overseas localisation in Poland, Mexico (about USD 84 million) and Morocco to capture nearshoring [Marklines; IR26H1].
  • Petrochemical cycle recovery via global closures (more than 15 Mt) and the PDH retrofit restart in H2 2026 [Lanjinger; IR26H1].
  • Recycled-content mandates: national award-winning recycling technology; 268.5 kt of waste plastics recycled in 2024 [ESG].
  • Rising modification rate in China (about 25% vs about 50% globally) [CSJ, Mar 2025].

Threats

  • Persistent PP/ABS oversupply from new Chinese capacity (Wanhua, Satellite, Hengli and others) [BF-Sep26].
  • Propane cost spikes from Middle East conflict, compressing PDH spreads to about CNY 1,965/t [BF-Sep26; IR26H1].
  • Trade and FDI barriers in the US and EU (management cites FDI screening as a top compliance risk) [IR26H1].
  • FX volatility: H1 2026 financial expense +43.94% [IR26H1].
  • Pricing pressure in new materials: Q1 2026 new-materials ASP −8.22% while raw-material costs rose 6.2% [SS-Apr26].
  • Customer concentration in cyclical durables (autos, appliances), exposed to the expiry of trade-in subsidies.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
21 Apr 2025FY2024 results: revenue CNY 60.51 billion (+26.23%), net profit CNY 825 million (+160.36%); Q1 2025 revenue CNY 15.67 billion (+49.06%), net profit CNY 247 million (+138.2%) Changcheng Securities (Apr 2025)Confirms recovery from FY2023 trough
25 Apr–8 Jul 2025Xiong Haitao sells 26.36 million shares [BF-Sep26]Insider-related selling into rally
Apr 2025Investor Q&A: openness to new-materials M&A "while keeping FCF healthy"; petrochemicals at "cyclical bottom" Securities Star (Apr 2025)Capital-allocation signal
30 Apr 2025Ningbo 1.2 Mt PP/TPE integration project capitalised [IR26H1]Raises depreciation at Ningbo
13 May (2025)Mexico investment of about USD 84 million in Villa de Reyes reported MarklinesNorth America localisation
Jul 2025Kingfa India Q1 FY26 revenue INR 4.62 billion (+10.93%); board changes (Sun Yajie executive director, S.K. Subramanyan independent director; Wu Xiaohui resigns) FilingReader (30 Jul 2025)Subsidiary governance
Aug 2025H1 2025: revenue CNY 31.64 billion (+35.50%), net profit CNY 597 million (+54.12%); medical gross margin −29.27% Securities Star (Sep 2025)Strong volume, medical weakness
Apr–Sep 2025Shares rise from CNY 8.64 to CNY 23.77–24.08 on "Unitree proxy" theme [BF-Sep26]; [F10]Valuation re-rating, retail inflow (holders +94% in Q3 2025)
19 Sep 2025Results call: specialty-plastics capacity about 34 kt; LCP H1 volumes +98.94%; Unitree look-through stake 0.32%; "333" target SinaGrowth roadmap disclosure
20 Sep 2025Xiong Haitao discloses plan to sell up to 26.37 million shares (only about 3 million sold) [BF-Sep26]Overhang
28 Oct 20259M 2025: revenue CNY 49.62 billion (+22.62%), net profit CNY 1.065 billion (+55.86%); specialty plastics 24 kt (+53.85%); PBAT capacity 180 kt DoNewsMomentum
Feb 2026Kingfa India Dec-2025 quarter net profit +30.44% Arihant CapitalOverseas earnings
20–21 Apr 2026FY2025 results: revenue CNY 65.40 billion (+8.07%), net profit CNY 1.150 billion (+39.44%), OCF CNY 5.90 billion (+107.52%), DPS CNY 0.20 [AR25]; [STCN]Earnings and FCF inflection
21 Apr 2026Q1 2026: revenue CNY 15.59 billion (−0.49%), net profit CNY 305 million (+23.72%) Securities Star (Jun 2026)Mix-driven profit growth on flat sales
24 Apr 2026Critical media coverage of CNY 9.72 billion... corrected: CNY 972 million impairments, negative petrochemical, trading and medical margins, and short-term debt above CNY 8.5 billion [SS-Apr26]Balance-sheet scrutiny
H1 20262026 restricted-share grant (38.47 million shares at CNY 9.52, 1,130 grantees) and 2026 ESOP (54.87 million shares) [BF-Sep26]; [F10]Retention; dilution of about 1.4% from restricted shares
Q2 20268 kt/yr transparent/specialty polyamide project commissioned on schedule [IR26H1]Specialty capacity
H1 2026Morocco subsidiary incorporated [IR26H1]Footprint expansion
H1 2026National S&T Progress Award (2nd class) for plastics-recycling technology [IR26H1]Recognition
29 Jun 2026Investor platform: look-through Unitree stake about 0.25% [F10]Clarifies exposure
19 Aug 2026Unitree STAR listing; Kingfa shares drop sharply intraday (prior 20-day gain 15.90%) [F10]Theme unwind
24–25 Aug 2026H1 2026: revenue CNY 34.12 billion (+7.85%), net profit CNY 685 million (+17.02%), OCF CNY 2.17 billion (+116.27%); overseas +24.46%; new materials revenue +41.38%; financial expense CNY 642 million (+43.94%, FX); asset impairment CNY 224 million [IR26H1]Solid core; petrochemical drag persists
25 Aug 2026Interim dividend CNY 0.10/share (about CNY 267 million; 38.92% payout); buyback completed (61.98 million shares cumulative at average CNY 7.283) [F10]; [IR26H1]Shareholder returns
27 Aug 2026Guosen maintains "Outperform"; Southwest initiates "Buy", target CNY 17.64 Guosen; SouthwestSell-side support
8 Sep 2026Investor-relations record: AI-compute and robotics materials positioned as new growth curves for next two years [BF-Sep26]Narrative
15 Sep 2026EGM: independent director election; repurchased shares to be cancelled; articles amended [F10]Capital reduction
18 Sep 2026Media scrutiny of executive pay (CNY 4.48 million and CNY 4.31 million) and incentive grants relative to returns [BF-Sep26]Governance optics
30 Sep 2026Shares close at CNY 12.76, about 47% below the 52-week high of CNY 24.08 StockAnalysisDe-rating

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

7 charts
Income Statement: Revenue & Gross Profit: Revenue rose from CNY 40,199 Mn in FY2021 to CNY 65,396 Mn in FY2025.
Kingfa Sci. & Tech. Co., Ltd. — Income Statement: Revenue & Gross Profit
Series (CNY Mn)FY2021FY2022FY2023FY2024FY2025
Revenue40,19940,41247,94160,51465,396
Gross profit6,4665,9195,5436,6138,384

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.